"ADORA3" Related Products


Recombinant Human ADORA3 Protein

Cat.No.: ADORA3-371H
Product Overview: Human ADORA3 full-length ORF (NP_000668.1) recombinant protein without tag.
Description: This gene encodes a protein that belongs to the family of adenosine receptors, which are G-protein-coupled receptors that are involved in a variety of intracellular signaling pathways and physiological functions. The receptor encoded by this gene mediates a sustained cardioprotective function during cardiac ischemia, it is involved in the inhibition of neutrophil degranulation in neutrophil-mediated tissue injury, it has been implicated in both neuroprotective and neurodegenerative effects, and it may also mediate both cell proliferation and cell death. Alternative splicing results in multiple transcript variants. This gene shares its 5' terminal exon with some transcripts from overlapping GeneID:57413, which encodes an immunoglobulin domain-containing protein. [provided by RefSeq, Nov 2014]
Source: Wheat Germ
Species: Human
Form: Liquid
Molecular Mass: 36.2 kDa
Applications: Antibody Production
Functional Study
Compound Screening
Usage: Heating may cause protein aggregation. Please do not heat this product before electrophoresis.
Notes: Best use within three months from the date of receipt of this protein.
Storage: Store at -80 centigrade. Aliquot to avoid repeated freezing and thawing.
Storage Buffer: 25 mM Tris-HCl of pH 8.0 containing 2% glycerol.
Gene Name: ADORA3 adenosine A3 receptor [ Homo sapiens ]
Official Symbol: ADORA3
Synonyms: ADORA3; adenosine A3 receptor; adenosine receptor A3; AD026; A3AR; bA552M11.5; RP11-552M11.7;
Gene ID: 140
mRNA Refseq: NM_000677
Protein Refseq: NP_000668
MIM: 600445
UniProt ID: P33765

Online Inquiry

Note: There will be extra charge for optional service!

Please input "biomart" as verification code. Please review Creative BioMart's privacy policy for more information

Optional requirements on this protein    +Expand

Price Inquiry

Welcome! For price inquiries, please feel free to contact us through the form below. We will get back to you as soon as possible.